Your browser doesn't support javascript.
loading
Safety of PCSK9 inhibitors.
Grzesk, Grzegorz; Dorota, Bednarska; Wolowiec, Lukasz; Wolowiec, Anna; Osiak, Joanna; Kozakiewicz, Mariusz; Banach, Joanna.
  • Grzesk G; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Dorota B; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Wolowiec L; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland. Electronic address: lordtor111@gmail.com.
  • Wolowiec A; Department of Geriatrics, Division of Biochemistry and Biogerontology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Osiak J; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Kozakiewicz M; Department of Geriatrics, Division of Biochemistry and Biogerontology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Banach J; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Biomed Pharmacother ; 156: 113957, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36411665

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Inhibidores de PCSK9 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Inhibidores de PCSK9 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article